Karsten Witt
Presidente presso KW Biotech Consulting LLC
Posizioni attive di Karsten Witt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KW Biotech Consulting LLC | Presidente | 01/02/2013 | - |
Storia della carriera di Karsten Witt
Precedenti posizioni note di Karsten Witt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2019 | 08/09/2020 |
| Corporate Officer/Principal | 08/09/2020 | 01/06/2022 | |
| ARRAY TECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 09/09/2011 | 01/01/2013 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2002 | - |
| TOPOTARGET A/S | Direttore/Membro del Consiglio | 30/08/2011 | - |
| Independent Dir/Board Member | 29/08/2011 | - |
Formazione di Karsten Witt
| University of Copenhagen | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Danimarca | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
| KW Biotech Consulting LLC |
- Borsa valori
- Insiders
- Karsten Witt
- Esperienza